Filing Details

Accession Number:
0001239241-15-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-19 20:58:32
Reporting Period:
2015-06-17
Filing Date:
2015-06-19
Accepted Time:
2015-06-19 20:58:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594864 Juno Therapeutics Inc. JUNO Biological Products, (No Disgnostic Substances) (2836) 463656275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239241 B Anthony Evnin C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-17 90,141 $51.59 1,659,858 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-17 94,080 $52.65 1,565,778 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-17 63,574 $53.84 1,502,204 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-17 28,603 $54.70 1,473,601 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-17 11,602 $55.85 1,461,999 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-17 12,000 $56.32 1,449,999 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-18 78,569 $52.07 1,371,430 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-18 154,495 $52.74 1,216,935 No 4 S Indirect By Funds
Common Stock Disposition 2015-06-18 50,269 $53.58 1,166,666 No 4 S Indirect By Funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
No 4 S Indirect By Funds
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 75,000 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") on May 18, 2015.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.07 to $52.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) - (19) to this Form 4.
  3. Consists of 1,403,176 shares held by VHCP and 256,682 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $53.10, inclusive.
  5. Consists of 1,323,641 shares held by VHCP and 242,137 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.13 to $54.12, inclusive.
  7. Consists of 1,269,896 shares held by VHCP and 232,308 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.13 to $55.12, inclusive.
  9. Consists of 1,245,715 shares held by VHCP and 227,886 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.13 to $56.12, inclusive.
  11. Consists of 1,235,907 shares held by VHCP and 226,092 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.13 to $56.82, inclusive.
  13. Consists of 1,225,762 shares held by VHCP and 224,237 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.35 to $52.34, inclusive.
  15. Consists of 1,159,340 shares held by VHCP and 212,090 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.35 to $53.34, inclusive.
  17. Consists of 1,028,730 shares held by VHCP and 188,205 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
  18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.35 to $54.00, inclusive.
  19. Consists of 986,233 shares held by VHCP and 180,433 shares held by VHCP Co-Invest. VHCP Management, LLC, or VHCP Management, is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. The reporting person is a member of VHCP Management and may be deemed to beneficially own these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.